Federica Cavallo

Università Cattolica del Sacro Cuore — Italy

Immunology and Microbiology · Life Sciences

61h-index13.3kcitations580works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(229), Monoclonal and Polyclonal Antibodies Research(92), CAR-T cell therapy research(81), Virus-based gene therapy research(80), Cancer Research and Treatments(77)

Publications579 total

“Summertime sadness”: Striatal dopamine binding decreases during warmer seasons in patients with severe depression
Psychiatry Research Neuroimaging·2026Open Access
Polatuzumab Vedotin and Glofitamab for Relapsed/Refractory Diffuse Large B‐Cell Lymphoma in the Compassionate Use Program in Italy
Hematological Oncology·2025Open Access
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer
Cancers·2025Open Access
Artificial intelligence and tacit knowledge in radio content production
Journal of Knowledge Management·2025
Integrated clinical and radiomic PET-FLIPI score for risk stratification in newly diagnosed follicular lymphoma
Blood·2025Open Access
Ibrutinib plus R-CHOP followed by maintenance in untreated ABC-DLBCL patients with IPI ≥2: A first analysis of phase II Study  FIL_RI-CHOP
Blood·2025Open Access
Pattern of infections and impact on immunocompetence of next generation B-cell depleting immunotherapies in non-Hodgkin's lymphomas: Results from a multicentre retrospective real- life cohort.
Blood·2025Open Access
Influence of the extent of cervical lymph node dissection and lymph nodes metastases on prognosis in a cohort of dogs with oral malignant melanoma treated by surgical resection and adjuvant anti-CSPG4 electrovaccination: a retrospective study on 77 cases
Frontiers in Veterinary Science·2025Open Access
287 | SHORT‐TERM DOSE‐DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV‐ AND HIV+ PATIENTS WITH BURKITT LYMHOMA
Hematological Oncology·2025Open Access
834 | LIFESTYLES IMPLEMENTED‐SURVIVORSHIP CARE PLAN IN LYMPHOMA SURVIVORS: AN ONGOING RANDOMIZED CLINICAL TRIAL BY THE FONDAZIONE ITALIANA LINFOMI
Hematological Oncology·2025Open Access
447 | POLATUZUMAB‐CONTAINING REGIMENS AS BRIDGE TO CAR‐T: INSIGHTS FROM THE ITALIAN CAR T‐SIE STUDY
Hematological Oncology·2025Open Access
277 | PREPHASE TREATMENT WITH VITAMIN D SUPPLEMENTATION IN OLDER PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA: A RANDOMIZED TRIAL BY FONDAZIONE ITALIANA LINFOMI
Hematological Oncology·2025Open Access
314 | ISOLATED CENTRAL NERVOUS SYSTEM RELAPSE AFTER CAR‐T CELL INFUSION IN LARGE B‐CELL LYMPHOMAS: AN ANALYSIS FROM THE ITALIAN CART‐SIE STUDY
Hematological Oncology·2025Open Access
Ankyloblepharon–Ectodermal Defects–Cleft Lip/Palate Syndrome-Linked p63 Mutations Disrupt Keratinocyte Proliferation and Survival Through Oxidative Stress and Impaired Slc7a11 Expression
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub‐Study of the <scp>FOLL12</scp> Trial
American Journal of Hematology·2025· 3 citedOpen Access
Comparative Effectiveness of R‐miniCOMP Versus R‐miniCHOP in Older Non‐Fit Patients With Diffuse Large B‐Cell Lymphoma: Insights From a “Fondazione Italiana Linfomi” Cohort Study
Hematological Oncology·2025· 3 cited
Author response for "Comparative Effectiveness of R‐miniCOMP Versus R‐miniCHOP in Older Non‐Fit Patients With Diffuse Large B‐Cell Lymphoma: Insights From a “Fondazione Italiana Linfomi” Cohort Study"
2025
Abstract 5846: A potent STING agonist induces endothelial PD-L1 and enhances antitumor efficacy of a novel PD-L1/PD-L2 antibody
Cancer Research·2025
Abstract 7304: Cytotoxic PD-L1/PD-L2 dual-specific antibodies couple tumor stroma remodeling with checkpoint blockade to drive rejection of “cold” cancers
Cancer Research·2025
Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols
Veterinary Quarterly·2025· 3 citedOpen Access
page 1 of 29Next →

Frequent Co-authors

Guido Forni(20), Piero Musiani(16), Mirella Giovarelli(12), Pier‐Luigi Lollini(11), Mario P. Colombo(10), Patrizia Nanni(8), Andrea Modesti(8), Laura Conti(8), Carla De Giovanni(7), Emma Di Carlo(6), Elena Quaglino(6), Manuela Iezzi(5), Stefania Lanzardo(5), Giordano Nicoletti(4), Lorena Landuzzi(4), Claudia Curcio(4), G Forni(4), Alessandra Allione(4), Rolf Kiessling(3), Sjoerd H. van der Burg(3)